Zobrazeno 1 - 10
of 25
pro vyhledávání: '"N. V. Solenkova"'
Autor:
Gross Gj, Leonid N. Maslov, Peter R. Oeltgen, A Iu Liishmanov, D. L. Stakheev, Budankova Ev, W S Chang, E. I. Barzakh, N. V. Solenkova
Publikováno v:
Biology Bulletin. 32:375-380
Preliminary selective blockade of micro, delta1, delta2, kappa1, and kappa2 opioid receptors proved to have no effect on the incidence of ventricular arrhythmias during a 10-min coronary occlusion and subsequent reperfusion in ketamine-anesthetized r
Autor:
Budankova Ev, Leonid N. Maslov, N. V. Naryzhnaya, E. I. Barzakh, Yu. B. Lishmanov, D. L. Stakheev, Peter R. Oeltgen, Garrett J. Gross, N. V. Solenkova
Publikováno v:
Bulletin of Experimental Biology and Medicine. 139:172-175
Preliminary selective block of mu-, delta1-, delta2-, and kappa-opioid receptors had no effect on the incidence of ventricular arrhythmias during 10-min coronary occlusion-reperfusion in ketamine-narcotized rats. Repetitive short-term immobilization
Publikováno v:
Bulletin of Experimental Biology and Medicine. 135:55-58
During aconitine-induced arrhythmias the antiarrhythmic effect of DALDA (Tyr-D-Arg-Phe-Lys-NH2) and nociceptin (orphanin FQ) administered intravenously depended on activation of nitric oxide synthase. KATP channels were not involved in the realizatio
Autor:
Galina A. Chernysheva, A. V. Krylatov, Y. Zhang, Leonid N. Maslov, Krieg T, A. Yu. Lishmanov, S. Yu. Cybulnikov, N. V. Solenkova, Barzakh Ei
Publikováno v:
Bulletin of Experimental Biology and Medicine. 149:591-593
The cardioprotective properties of a δ₂-opioid receptor agonist deltorphin II were studied in rats with coronary occlusion and reperfusion. Opioid receptor ligands and inhibitors (glybenclamide, chelerythrine, and 5-hydroxydecanoate) were injected
Autor:
L N, Maslov, E I, Barzakh, A V, Krylatov, G A, Chernysheva, T, Krieg, N V, Solenkova, A Yu, Lishmanov, S Yu, Cybulnikov, Y, Zhang
Publikováno v:
Bulletin of experimental biology and medicine. 149(5)
The cardioprotective properties of a δ₂-opioid receptor agonist deltorphin II were studied in rats with coronary occlusion and reperfusion. Opioid receptor ligands and inhibitors (glybenclamide, chelerythrine, and 5-hydroxydecanoate) were injected
Autor:
L N, Maslov, E I, Barzakh, A V, Krylatov, S A, Brown, P R, Oeltgen, M, Govindaswami, G A, Chernysheva, N V, Solenkova, A Iu, Lishmanov, S Iu, Tsibul'nikov, T, Krieg, E, Zhang
Publikováno v:
Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova. 95(6)
The study aimed at investigation of the role of opioid receptor (OR) in regulation of cardiac tolerance to ischemia-reperfusion. Opioid receptor ligands and inhibitors were administered in vivo prior to coronary artery occlusion (45 min) and reperfus
Publikováno v:
Uspekhi fiziologicheskikh nauk. 37(3)
It has been systematized modem data on the early phase of ischemic preconditioning and cardiac resistance to pathogenic action of ischemia and reperfusion. It has been performed an analysis published works on the important role of alteration of myoca
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 69(2)
The state-of-the-art in investigations of the mu-opioid receptors (ORs) is reviewed. Published information on the interaction between mu-ORs and various G-proteins is summarized and data on the neutral antagonists and inverse agonists of mu-opioid re
Publikováno v:
Patologicheskaia fiziologiia i eksperimental'naia terapiia. (2)
Autor:
N V, Solenkova, L N, Maslov, E V, Budankova, A Iu, Lishmanov, P, Oeltgen, M, Govindaswami, Zh D, Bespalova, M V, Ovchinnikov, H, Nagaze
Publikováno v:
Eksperimental'naia i klinicheskaia farmakologiia. 68(6)
It has been established that pretreatment with the selective mu-opioid receptor (OR) agonist DALDA (0.1 mg/kg, i.v.) or the selective delta1-OR agonists DPDPE (0.09 mg/kg) and/or (-)-TAN-67 (0.08 mg/kg) has no effect on the incidence of ventricular a